Epinogen Co. is an R&D company developing next-generation anticancer drugs utilizing advanced Cryo-EM technology.

Vision and Mission: Their mission is to innovate in the field of oncology, providing effective treatment options for breast, colorectal, and other cancers.

Noteworthy Points:

• Pioneering with a new drug development platform combining cryo-EM and AI.
• Has a robust pipeline with leading and follow-up projects.